RELEASE OF THE MUCOSAL MAST-CELL GRANULE CHYMASE, RAT MAST-CELL PROTEASE-II, DURING ANAPHYLAXIS IS ASSOCIATED WITH THE RAPID DEVELOPMENT OFPARACELLULAR PERMEABILITY TO MACROMOLECULES IN RAT JEJUNUM
Cl. Scudamore et al., RELEASE OF THE MUCOSAL MAST-CELL GRANULE CHYMASE, RAT MAST-CELL PROTEASE-II, DURING ANAPHYLAXIS IS ASSOCIATED WITH THE RAPID DEVELOPMENT OFPARACELLULAR PERMEABILITY TO MACROMOLECULES IN RAT JEJUNUM, The Journal of experimental medicine, 182(6), 1995, pp. 1871-1881
The soluble granule chymase, rat mast cell protease-II (RMCP-II), is a
bundantly expressed in intestinal mucosal mast cells (MMC) but its fun
ction is not known. One hypothesis is that RMCP-II degrades the epithe
lial basement membrane and promotes the loss of enterocytes typically
associated with type I hypersensitivity reactions in the rat. To test
this hypothesis more directly, ex vivo perfusion of the cranial mesent
eric artery and jejunal lumen was used to monitor the anaphylactic rel
ease of RMCP-II and its effects on mucosal permeability and epithelial
integrity. Within 2 min of intravascular challenge with soluble adult
Nippostrongylus brasiliensis worm antigen there was a 1,000-fold (P<0
.02) increase in the concentration of RMCP-II in the vascular perfusat
e from the jejunum of Nippostrongylus-sensitized rats but not the cont
rols. Similarly, translocation of RMCP-II into the gut lumen increased
10-fold (P<0.02) after 2 min only in worm antigen-challenged immune r
ats. Using an identical protocol, but incorporating Evans blue-labeled
human serum albumin (EB-HSA) in the vascular perfusate, the timing of
the release of RMCP-II into the two compartments was very similar to
the first experiment and furthermore the translocation of EB-HSA incre
ased 18-fold (P<0.05) after 4 min in sensitized rats challenged with w
orm antigen. To examine the effects of RMCP-II more directly 1 mg of t
he highly purified chymase was introduced into the cranial mesenteric
artery in ex vivo perfused normal rats. A significant (P<0.05) 70-fold
increase in concentration of RMCP-II in jejunal perfusate occurred af
ter 6 min. In a repeat dose-response experiment, infusion of 0.375, 0.
75, or 1.5 mg of RMCP-II, together with EB-HSA, established that the c
umulative amounts of RMCP-II and EB-HSA translocated from the vasculat
ure to the gut lumen in each perfusion (during the 10-min period of RM
CP-II infusion) were significantly correlated. Analysis of intestinal
perfusates by SDS-PAGE and by Western blotting using monoclonal anti-R
MCP-II antibody confirmed that there was a concomitant translocation o
f both the protease and EB-HSA into the gut lumen. Histological evalua
tion of the mucosa failed to reveal any significant morphological chan
ge in any of the experiments. The rapid development of macromolecular
leak, its association with the translocation of RMCP-II, and the absen
ce of gross epithelial lesions, suggest for the first time that a mast
cell granule chymase increases epithelial permeability via a paracell
ular route and implies that the substrate may be a protein, or protein
s, in the epithelial junctional complex.